4 ms·
Former Reuters COO is on the board of Pfizer. J&J is a vaccine competitor of Pfizer. To a reasonable person, this might be something of interest.
by briandear 5y ago
Former Reuters COO is on the board of Pfizer. J&J is a vaccine competitor of Pfizer. To a reasonable person, this might be something of interest.
- resoluteteeth 5y agoThat seems like an extreme stretch unless you have have some reason to think that Reuters wouldn't have normally reported something like this and the COO intervened or something like that.